C12Y 207/01048
Uridine kinase
Official title: Uridine kinase (2.7.1.48)
C12Y207/01048 (Uridine kinase) appears on 6 US grants and 8 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 8
- Assignees
- 7
- Inventors
- 47
- Latest grant
- 15 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 1 |
| 2019 | 1 | 2 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Enzymatic method for preparation of CMP-Neu5Ac15 Apr 2025US 12,275,973 B2Max-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V.
- Genetically engineered bacterium used for producing uridine with high-yield21 Sep 2021US 11,124,780 B2Tianjin University of Science and Technology
- Fluorocyclopentenylcytosine methods of use7 May 2019US 10,278,971 B2Rexahn Pharmaceuticals, Inc.
- Fluorocyclopentenylcytosine methods of use10 Oct 2017US 9,782,410 B2Rexahn Pharmaceuticals, Inc.
- 57658, a novel human uridine kinase and uses thereof31 May 2005US 6,900,303 B2Millennium Pharmaceuticals, Inc.
- Enzymatic method for preparation of cmp-neu5ac24 Oct 2024US 2024/0352497 A1Max-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V.
- Fluorocyclopentenylcytosine methods of use12 Sep 2019US 2019/0275042 A1Rexahn Pharmaceuticals, Inc.
- Genetically engineered bacteria used for producing uridine with high-yield and its construction method and use29 Aug 2019US 2019/0264185 A1Tianjin University of Science and Technology
- Fluorocyclopentenylcytosine methods of use25 Jan 2018US 2018/0021338 A1Rexahn Pharmaceuticals, Inc.
- Fluorocyclopentenylcytosine methods of use19 Jan 2017US 2017/0014411 A1Rexahn Pharmaceuticals, Inc.
Most cited
By later US patents